As the problem of antibiotic resistance in the U.S. escalates with the discovery of the superbug mcr-1 gene in the country, drug industry experts are calling for new financial incentives for antibiotic research and development.
As the problem of antibiotic resistance in the U.S. escalates with the discovery of the superbug mcr-1 gene in the country, drug industry experts are calling for new financial incentives for antibiotic research and development.
Share this Article
Recommended